Pharmacy- Page 48

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Biogen Announces Collaboration with University of Pennsylvania on Multiple Gene Therapy Programs

The FINANCIAL -- Biogen on May 16 announced a broad collaboration and alliance with the University of Pennsylvania (“Penn”) to advance gene therapy and gene editing technologies.

by The FINANCIAL

May 17, 2016

3 mins read

Pharmacy

AstraZeneca announces positive results from benralizumab phase III programme in severe asthma

The FINANCIAL -- AstraZeneca on May 17 announced that benralizumab, a potential new medicine and anti-eosinophil monoclonal antibody, was well tolerated and achieved the primary endpoint in two pivotal Phase III registrational trials (SIROCCO and CALIMA), demonstrating significant reductions in the annual

by The FINANCIAL

May 17, 2016

1 min read

Pharmacy

Pfizer To Acquire Anacor

The FINANCIAL -- Pfizer Inc. and Anacor Pharmaceuticals, Inc. on May 16 announced that they have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share, in cash, for a total transaction value, net of

by The FINANCIAL

May 16, 2016

3 mins read

Pharmacy

Novartis Announces NEJM Publication Of Head-to-head FLAME Study

The FINANCIAL -- Novartis on May 15 announced the New England Journal of Medicine publication of the head-to-head FLAME study comparing the efficacy of once-daily Ultibro Breezhaler (indacaterol/glycopyrronium bromide) 110/50 mcg to twice-daily Seretide (salmeterol/fluticasone [SFC]) 50/500 mcg in reducing chronic obstructive

by The FINANCIAL

May 16, 2016

1 min read

Pharmacy

New claim for use of Metacam 20mg/ml in sheep simultaneously granted in Australia, Canada and New Zealand

The FINANCIAL -- Health Canada, the Australian Pesticides and Veterinary Medicines Authority (APVMA) and the New Zealand Ministry for Primary Industries (NZMPI) have simultaneously approved a new use for pain relief in sheep for the veterinary drug Metacam 20mg/ml.

by The FINANCIAL

May 11, 2016

1 min read

Pharmacy

Allergan Reports Strong First Quarter 2016 Continuing Operations Performance

The FINANCIAL -- Allergan plc reported strong performance with net revenue from continuing operations increasing 48 percent to $3.8 billion for the quarter ended March 31, 2016, compared to $2.6 billion in the first quarter 2015.

by The FINANCIAL

May 11, 2016

6 mins read

Pharmacy

Daiichi Sankyo Signs License Agreement with Cell Therapy Ltd. for Heartcel（TM）

The FINANCIAL -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), on May 10 announced the signing of a license agreement with UK-based Cell Therapy Ltd. (hereafter, CTL) for an exclusive license in Japan to develop and market Heartcel, a immune-modulatory progenitor (iMP)

by The FINANCIAL

May 11, 2016

1 min read

Pharmacy

Takeda Pharmaceutical Posts FY Profit

The FINANCIAL -- Christophe Weber, President and Chief Executive Officer of Takeda, commented:

by The FINANCIAL

May 10, 2016

2 mins read

Pharmacy

Merck Q1 Adj. Profit Tops View, But Sales Miss

The FINANCIAL -- Merck, known as MSD outside the United States and Canada, on May 5 announced financial results for the first quarter of 2016.

by The FINANCIAL

May 5, 2016

5 mins read

Pharmacy

Biogen Announces Intent to Spin off Its Hemophilia Business

The FINANCIAL -- Biogen Inc. on May 3 announced that it intends to spin off its hemophilia business as an independent, publicly traded company. The strategic goal of this transaction is to create two focused companies dedicated to driving current and future value in

by The FINANCIAL

May 4, 2016

4 mins read